13 research outputs found
Temu "dizajniranja" (muzejskih izložaba) gledamo vrlo Ŕiroko i otvoreno
Oblikovanje izložaba vidimo kao jedan od najpotentnijih alata za stvaranje i prezentaciju novog znanja na temelju akumulacije postojeÄih znanja. Radi komuniciranja izložbenog narativa, otvoreni smo za sve medije, materijale i pristupe oblikovanju, od ambijentalnih, tekstualno-informativnih, multimedijskih, grafiÄko-ilustrativnih ili pak participativnih. Balansiranje odnosa izmeÄu odabira pristupa i koriÅ”tenja medijima u odnosu prema temi odreÄuje karakter konaÄnog rjeÅ”enja
M8: The Adriatic Highway: Infrastructure as a Generator of Territory
Infrastruktura kao generator teritorija jest umjetniÄko istraživanje koje koristi likovnu analizu kao osnovu razvijanja kvalitativnih kartografskih metoda izvan egzaktnih okvira geoinformacijskih tehnologija. Uloga Jadranske magistrale ponajprije u turistiÄkim transformacijama prethodno nepovezanog i nerazvijenoga agrikulturnog dužobalnog pojasa, analizirana kroz prvo sustavno koriÅ”tenje aerofotogrametrijskih snimaka iz razdoblja uoÄi njezina dovrÅ”etka 1965., služi kao organizacijska i sadržajna potka valorizacije ovoga opsežnog obuhvata. Sekvencija prolaska magistralom iskustveno je oblikovala ovaj prostor, rekombinirajuÄi njegove sastavnice na potpuno drugaÄiji naÄin u odnosu na prethodne itinerere koji su ga obuhvaÄali, poput shematizirane kasnoantiÄke Tabule Peutingeriane ili idealizirane kontinuirane panorame Giuseppea Riegera iz 1853. Transformacijom izvorne rute i izmjeÅ”tanjem prometa na trasu buduÄe Jadransko-jonske autoceste nastavlja se vizualna reorganizacija obalnog prostora. Postupkom bliskim klasiÄnim metodama sažimanja videosekvencija, magistrala je takoÄer podijeljena u sekvencije, a potom na arbitraran broj toÄaka koje Äine nasuprotno snimljeni fotografski prikazi. Na njima se umjesto kontinuiteta analiziraju upravo prekidi i promjene u njemu, kao svojevrsni komprimirani zapis kojima se iskljuÄuju istovjetni podaci. Kroz niz jednostavnih odrednica koje ih karakteriziraju prate se transformacijski procesi, dominantno koriÅ”tenje zemljiÅ”ta, elementi prirodnog ili izgraÄenog okoliÅ”a. Ovako se stvara otvorena matrica podataka koja omoguÄava rekombiniranje elemenata, ovisno o odabranoj metodi klasifikacije. Kroz statistiÄku uÄestalost prevladava se inicijalna arbitrarnost i izgraÄuju kartografske sekvencije kojima se detektiraju intrigantni obrasci i nova sagledavanja prostora.Infrastructure as a Generator of Territory is an art project that uses visual analysis in order to develop qualitative cartographic methods beyond the exact boundaries of geoinformatic technologies. The role of the Adriatic Highway in the transformations of the previously disconnected and underdeveloped agricultural litoral took place primarily owing to tourism. This has been analyzed by using, for the first time systematically, aerophotogrametric surveys from the period preceding its completiton (1965). The highway has been the organizational and conceptual basis for evaluating this extensive undertaking. The sequence of passage along the Magistral road has structured this space experientially by recombining its components in an entirely different way as compared to the previous itineraries, represented in the schematized late antique Peutingeriana or the idealized continuous panorama of Giuseppe Rieger from 1853. By transforming the original route and displacing the trafic to the future Adriatic-Ionian, motorway the visual reorganization of the literal was continued. By using a procedure similar to the classical methods of contracting video sequences, the Adriatic Highway has likewise been divided into sequences and then further to an arbitrary number of points rendered by the photographic scenes shot from the opposing angles. Rather than showing the continuities, they primarily analyze disruptions and transformations as a sort of comprimated recording that excludes identical data. A series of simple defining features makes it possible to observe the transformation processes, the prevalent uses of land, and the elements of natural or human-made environment. This creates a matrix of data that allows for a recombination of elements, depending on the selected method of classification. Statistical frequency helps overcome the initial arbitrariness and construct cartographic sequences that make it possible to detect intriguing patterns and to view space in a fresh way
Temu "dizajniranja" (muzejskih izložaba) gledamo vrlo Ŕiroko i otvoreno
Oblikovanje izložaba vidimo kao jedan od najpotentnijih alata za stvaranje i prezentaciju novog znanja na temelju akumulacije postojeÄih znanja. Radi komuniciranja izložbenog narativa, otvoreni smo za sve medije, materijale i pristupe oblikovanju, od ambijentalnih, tekstualno-informativnih, multimedijskih, grafiÄko-ilustrativnih ili pak participativnih. Balansiranje odnosa izmeÄu odabira pristupa i koriÅ”tenja medijima u odnosu prema temi odreÄuje karakter konaÄnog rjeÅ”enja
KliniÄke upute za dijagnostiku, lijeÄenje i praÄenje bolesnika oboljelih od raka mokraÄnog mjehura Hrvatskoga onkoloÅ”kog druÅ”tva i Hrvatskoga uroloÅ”kog druÅ”tva Hrvatskoga lijeÄniÄkog zbora [Clinical guidelines for diagnosing, treatment and monitoring patients with bladder cancer - Croatian Oncology Society and Croatian Urology Society, Croatian Medical Association]
Urothelial cancer is the most common bladder cancer. Hematuria is the most common presenting symptom in patients with bladder cancer. The most common diagnostics of bladder cancer is performed by transurethral resection of bladder after which pathohistological diagnosis is set. It is necessary to determine whether the cancer penetrated in muscle layer (muscle-invasive cancer) or not (muscle-noninvasive cancer). Decision on therapeutic modality depends on the clinical stage of disease and on prognostic and risk factors. For muscle non-invasive bladder cancer transurethral resection is preferred with or without intravesical instillation of Bacillus Calmette-GuƩrin (BCG). For invasive cancer the method of choice is radical cystectomy. Radiotherapy is used in radical and palliative purposes. Metastatic disease is most frequently treated by chemotherapy metotrexate/vinblastine/doxorubicine/cisplatin (MVAC) or gemcitabine/cisplatin (GC). The purpose of this article is to present clinical recommendations to set standards of procedures and criteria in diagnostics, treatment and follow up of patients with bladder cancer in the Republic of Croatia
Clinical guidelines for diagnostics, treatment and monitoring of patients with testicular cancer
Rak testisa najÄeÅ”Äi je solidni tumor u muÅ”karaca u dobi od 15. do 34. godine. Incidencija raka testisa u svijetu udvostruÄena je u posljednjih 40 godina. Tumori zametnih stanica Äine 95% svih tumora testisa, a podijeljeni su u dva osnovna histoloÅ”ka tipa: seminomi i neseminomi. Osobito znaÄenje daje im velik postotak izljeÄivosti i u diseminiranoj fazi bolesti. Tom je uspjehu najviÅ”e pridonijela kemoterapija, ali kirurgija je i dalje neizostavan dio uspjeÅ”nog lijeÄenja. U znatnog dijela bolesnika danas se nastoji odrediti terapijski minimum kojim se izbjegava niz nuspojava, a dovodi do jednakog uspjeha kao i donedavno agresivniji terapijski pristup. U tekstu koji slijedi iznesene su kliniÄke upute radi standardizacije dijagnostike, lijeÄenja i praÄenja bolesnika s tumorima
zametnih stanica testisa u Republici Hrvatskoj.Testicular tumors are the most common solid tumors in men between age 15- 34 years. The worldwide incidence of these tumors has doubled in the past 40 years. Germ cell tumors comprise 95% of malignant
tumors arising in the testes and they are classified as seminoma and nonseminoma. Testicular cancer has high cure rates even in disseminated stage of disease. The chemotherapy mostly contributed to these results, but surgery is an unavoidable part of this success. In significant number of these patients treatment algorithms today
have intention to offer the same cure rates with minimally aggressive therapy. The following text presents the clinical guidelines in order to standardize procedures and criteria for diagnosis, treatment, and follow-up of patients with testicular cancer in the Republic of Croatia
CLINICAL GUIDELINES FOR DIAGNOSING, TREATMENT AND MONITORING PATIENTS WITH TESTICULAR CANCER ā CROATIAN ONCOLOGY SOCIETY AND CROATIAN UROLOGY SOCIETY, CROATIAN MEDICAL ASSOCIATION
Tumori testisa najÄeÅ”Äi su solidni tumori u muÅ”karaca u dobi od 15. do 34. godine. Njihova je incidencija u svijetu podvostruÄena u posljednjih 40 godina. Tumori zametnih stanica obuhvaÄaju 95% svih tumora testisa, a podijeljeni su u dva osnovna histoloÅ”ka tipa: seminomi i neseminomi. Osobito znaÄenje daje im visok postotak izljeÄivosti i u diseminiranoj fazi bolesti. Ovom uspjehu najviÅ”e je pridonijela kemoterapija, ali i dalje je kirurgija neizostavni dio uspjeÅ”nog lijeÄenja. Kod znatnog dijela ovih bolesnika danas se nastoji odrediti terapijski minimum kojim se izbjegava niz nuspojava, a koji dovodi do jednakog uspjeha kao i donedavno agresivniji terapijski pristup. U tekstu koji slijedi iznesene su kliniÄke upute radi standardizacije dijagnostike, terapije i kontrole bolesnika s tumorima zametnih stanica testisa u Republici Hrvatskoj.Testicular tumors are the most common solid tumors in men between 15 and 34 years of age. The worldwide incidence of these tumors has doubled in the past 40 years. Germ cell tumors comprise 95% of malignant tumors arising in the testes and they are classified either as seminoma or nonseminoma. Testicular cancers have a high cure rates even in disseminated stage of the disease. The chemotherapy mostly contributed to these results but surgery is an inevitable part of successful treatment. In a significant number of these patients treatment algorithms with minimum side effects are designed with the intention to maintain same cure rates as previously used, more aggressive therapy. The following text presents the clinical guidelines in order to standardize the procedures and criteria for diagnosis, management, treatment and follow-up of patients with testicular cancer in Republic of Croatia
Clinical recommendations for diagnosis, treatment and monitoring of patients with bladder cancer
Rak mokraÄnog mjehura (RMM) jest, u skladu s podatcima hrvatskog Registra za rak iz 2015. godine, drugi prema uÄestalosti tumor urinarnog sustava, odmah nakon raka prostate. U 90% sluÄajeva radi se o urotelnom karcinomu, a razlika u preživljenju kod bolesnika s miÅ”iÄnoinvazivnim RMM-om (MIRMM) i nemiÅ”iÄnoinvazivnim RMM-om (NMIRMM) znatna je. LijeÄenje NMIRMM-a usmjereno je na smanjenje recidiva i sprjeÄavanje napredovanja bolesti, a sastoji se od transuretralne resekcije (TUR) tumora i primjene intravezikalne terapije ovisno o procjeni rizika od povrata bolesti. Temelj lijeÄenja bolesnika s MIRMM-om jest radikalno kirurÅ”ko lijeÄenje, tj. cistektomija kojoj u bolesnika koji su sposobni primiti cisplatinu prethodi neoadjuvantna kemoterapija (NKT). U trenutku postavljanja dijagnoze bolest je kod 4 ā 6% bolesnika proÅ”irena, dok Äe se u 50% bolesnika razviti povrat bolesti nakon cistektomije. Metode lijeÄenja proÅ”irenje bolesti ukljuÄuju: kemoterapiju temeljenu na cisplatini, imunoterapiju, palijativnu radioterapiju te simptomatsko i potporno lijeÄenje. Važno obilježje RMM-a jest prisutnost visoke stope somatskih mutacija koje su omoguÄile promjenu paradigme u lijeÄenju proÅ”irenog RMM-a i dovele do odobravanja niza novih lijekova koji pripadaju inhibitorima PD-1 i PD-L1, tj. inhibitorima nadzornih toÄaka imunosnog odgovora posredovanog T-stanicama .Bladder cancer is the second most common malignancy of urinary system according to data from the Croatian National Cancer Registry for 2015. In 90% of cases the underlying histology is urothelial carcinoma.
Difference in survival in patients with muscle-invasive disease (MIBC) compared to the survival of patients with non-muscle invasive disease (NMIBC) is enormous. Management of NMIBC, traditionally, has been focused on the reduction of subsequent bladder recurrence and prevention of disease progression and is primarily based on transurethral resection (TUR) of the tumor, followed by intravesical therapy based on estimated individual risk of recurrence. Conversely, in patients with MIBC radical cystectomy remains the corne stone of the treatment, optimally in conjunction with neoadjuvant platinum-based chemotherapy in cisplatin-eligible patients. At the moment of
diagnosis, 4ā6% of patients already have distant metastases, and post cystectomy recurrence could be expected in 50% of patients. Treatment options in metastatic disease range from cisplatin-based chemotherapy, immunotherapy, palliative radiotherapy and finally supportive care. Landmark feature of bladder cancer is the high prevalence
of somatic mutations which enabled profound change for decades held treatment paradigm for advanced bladder cancer leading to regulatory approval of whole array of novel immunotherapy agents. These emerging therapeutics (programmed death ligand-1 (PD-L1) and programmed cell death protein-1 (PD-1)) belong to the
class of inhibitors of checkpoint proteins, which are key targets that regulate T-cell mediated immune response
CLINICAL GUIDELINES FOR DIAGNOSING, TREATMENT AND MONITORING PATIENTS WITH BLADDER CANCER ā CROATIAN ONCOLOGY SOCIETY AND CROATIAN UROLOGY SOCIETY, CROATIAN MEDICAL ASSOCIATION
Urotelni rak najÄeÅ”Äi je rak mokraÄnog mjehura. Hematurija je najÄeÅ”Äi simptom pri prezentaciji bolesti. Dijagnoza raka mokraÄnog mjehura postavlja se uglavnom transuretralnom resekcijom nakon Äega slijedi patohistoloÅ”ka dijagnoza. Nužno je utvrditi je li rak zahvatio miÅ”iÄni sloj (miÅ”iÄnoinvazivni rak) ili nije (miÅ”iÄnoneinvazivni rak). Odluka o terapijskome modalitetu ovisi o kliniÄkom stadiju bolesti, prognostiÄkim Äimbenicima i Äimbenicima rizika. Za miÅ”iÄnoneinvazivni rak mokraÄnog mjehura uglavnom se preferira transuretralna resekcija tumora mokraÄnog mjehura s intravezikalnom instilacijom Calmette-GuĆ©rinova bacila (BCG) ili bez nje. Za invazivni je rak metoda izbora radikalna cistektomija. Radioterapija se rabi u radikalne i palijativne svrhe. Metastatska bolest najÄeÅ”Äe se lijeÄi kemoterapijom metotreksat/vinblastin/doksorubicin/cisplatinom (MVAC) ili gemcitabin/cisplatinom (GC). Svrha je ovog Älanka predstavljanje kliniÄkih uputa s ciljem standardizacije postupaka i kriterija postavljanja dijagnoze, lijeÄenja te praÄenja bolesnika s rakom mokraÄnog mjehura u Republici Hrvatskoj.Urothelial cancer is the most common bladder cancer. Hematuria is the most common presenting symptom in patients with bladder cancer. The most common diagnostics of bladder cancer is performed by transurethral resection of bladder after which pathohistological diagnosis is set. It is necessary to determine whether the cancer penetrated in muscle layer (muscle-invasive cancer) or not (muscle-noninvasive cancer). Decision on therapeutic modality depends on the clinical stage of disease and on prognostic and risk factors. For muscle non-invasive bladder cancer transurethral resection is preferred with or without intravesical instillation of Bacillus Calmette-GuĆ©rin (BCG). For invasive cancer the method of choice is radical cystectomy. Radiotherapy is used in radical and palliative purposes. Metastatic disease is most frequently treated by chemotherapy metotrexate/vinblastine/doxorubicine/cisplatin (MVAC) or gemcitabine/cisplatin (GC). The purpose of this article is to present clinical recommendations to set standards of procedures and criteria in diagnostics, treatment and follow up of patients with bladder cancer in the Republic of Croatia
CLINICAL GUIDELINES FOR DIAGNOSING, TREATMENT AND MONITORING PATIENTS WITH BLADDER CANCER ā CROATIAN ONCOLOGY SOCIETY AND CROATIAN UROLOGY SOCIETY, CROATIAN MEDICAL ASSOCIATION
Urotelni rak najÄeÅ”Äi je rak mokraÄnog mjehura. Hematurija je najÄeÅ”Äi simptom pri prezentaciji bolesti. Dijagnoza raka mokraÄnog mjehura postavlja se uglavnom transuretralnom resekcijom nakon Äega slijedi patohistoloÅ”ka dijagnoza. Nužno je utvrditi je li rak zahvatio miÅ”iÄni sloj (miÅ”iÄnoinvazivni rak) ili nije (miÅ”iÄnoneinvazivni rak). Odluka o terapijskome modalitetu ovisi o kliniÄkom stadiju bolesti, prognostiÄkim Äimbenicima i Äimbenicima rizika. Za miÅ”iÄnoneinvazivni rak mokraÄnog mjehura uglavnom se preferira transuretralna resekcija tumora mokraÄnog mjehura s intravezikalnom instilacijom Calmette-GuĆ©rinova bacila (BCG) ili bez nje. Za invazivni je rak metoda izbora radikalna cistektomija. Radioterapija se rabi u radikalne i palijativne svrhe. Metastatska bolest najÄeÅ”Äe se lijeÄi kemoterapijom metotreksat/vinblastin/doksorubicin/cisplatinom (MVAC) ili gemcitabin/cisplatinom (GC). Svrha je ovog Älanka predstavljanje kliniÄkih uputa s ciljem standardizacije postupaka i kriterija postavljanja dijagnoze, lijeÄenja te praÄenja bolesnika s rakom mokraÄnog mjehura u Republici Hrvatskoj.Urothelial cancer is the most common bladder cancer. Hematuria is the most common presenting symptom in patients with bladder cancer. The most common diagnostics of bladder cancer is performed by transurethral resection of bladder after which pathohistological diagnosis is set. It is necessary to determine whether the cancer penetrated in muscle layer (muscle-invasive cancer) or not (muscle-noninvasive cancer). Decision on therapeutic modality depends on the clinical stage of disease and on prognostic and risk factors. For muscle non-invasive bladder cancer transurethral resection is preferred with or without intravesical instillation of Bacillus Calmette-GuĆ©rin (BCG). For invasive cancer the method of choice is radical cystectomy. Radiotherapy is used in radical and palliative purposes. Metastatic disease is most frequently treated by chemotherapy metotrexate/vinblastine/doxorubicine/cisplatin (MVAC) or gemcitabine/cisplatin (GC). The purpose of this article is to present clinical recommendations to set standards of procedures and criteria in diagnostics, treatment and follow up of patients with bladder cancer in the Republic of Croatia
Recikliraj, ideje iz proŔlosti
Znanstvena monografija Recikliraj, ideje iz proÅ”losti posveÄena je temi recikliranja i ponovne upotrebe u proÅ”losti, a nastala je u sklopu istoimene izložbe. Monografija sadrži 17 tekstova u okviru kojih se razmatraju ponovna upotreba predmeta i recikliranje razliÄitih vrsta materijala poput kamena, keramike, kosti, metala, stakla i tekstila kroz sva vremenska razdoblja. Tekstovi monografije, koji prate koncept izložbe, pokazuju da su reciklirani predmeti imali vrlo aktivnu ulogu u druÅ”tvu, da nisu izolirani sluÄajevi ponovne upotrebe odreÄenog materijala te da je ideoloÅ”ka pozadina, ponovne upotrebe i recikliranja, imala mnogo složenije znaÄenje za druÅ”tvo. PrateÄi osnovnu misao izložbe tekstovi u monografiji usmjereni su na podizanje svijesti o dugovjeÄnom i neprekinutom ciklusu ponovne upotrebe predmeta kako bi se Äitatelja potaklo na razmiÅ”ljanje o konceptu recikliranja u odnosu na suvremeni naÄin života.Znanstvena monografija Recikliraj, ideje iz proÅ”losti posveÄena je temi recikliranja i ponovne upotrebe u proÅ”losti, a nastala je u sklopu istoimene izložbe. Monografija sadrži 17 tekstova u okviru kojih se razmatraju ponovna upotreba predmeta i recikliranje razliÄitih vrsta materijala poput kamena, keramike, kosti, metala, stakla i tekstila kroz sva vremenska razdoblja. Tekstovi monografije, koji prate koncept izložbe, pokazuju da su reciklirani predmeti imali vrlo aktivnu ulogu u druÅ”tvu, da nisu izolirani sluÄajevi ponovne upotrebe odreÄenog materijala te da je ideoloÅ”ka pozadina, ponovne upotrebe i recikliranja, imala mnogo složenije znaÄenje za druÅ”tvo. PrateÄi osnovnu misao izložbe tekstovi u monografiji usmjereni su na podizanje svijesti o dugovjeÄnom i neprekinutom ciklusu ponovne upotrebe predmeta kako bi se Äitatelja potaklo na razmiÅ”ljanje o konceptu recikliranja u odnosu na suvremeni naÄin života